We divided the research into three parts: (1) the effect of the combination treatment on AD models, (2) the effect of the combination treatment on autophagy/mitophagy, and (3) the effect of the combination treatment on AD by affecting autophagy/mitophagy on PINK1/Parkin. Here, PRKN is linked to Alzheimer disease.